US 9060971
Combination pharmaceutical agents as inhibitors of HCV replication
granted A61KA61K31/13A61K31/4184
Quick answer
US patent 9060971 (Combination pharmaceutical agents as inhibitors of HCV replication) held by Enanta Pharmaceuticals, Inc. expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/13, A61K31/4184, A61K31/4196, A61K31/437